Global Cold Blister Packaging Effective Choice Pharmaceutical Market

Cold Blister Packaging Effective Choice Pharmaceutical Market Size, Share, Growth Analysis, By material(Paper & Paperboard, Plastics Films, Aluminium), By Type of technology(Thermoforming and Cold Forming), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35I2252 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 61 | Figures: 75

Cold Blister Packaging Effective Choice Pharmaceutical Market Insights

Cold Blister Packaging Effective Choice Pharmaceutical Market size was valued at USD 3.44 billion in 2021 and is poised to grow from USD 3.70 billion in 2022 to USD 6.60 by 2030, at a CAGR of 7.5% during the forecast period (2023-2030).

Cold form blister packs are made with Aluminum foil which is sandwiched between Polyvinyl Chloride (PVC) and nylon (oPA) films during the production of cold form blister packs utilising dry bond lamination technology. Without using heat, a stamp merely presses the film laminate into the mould. Consequently, the substance is known as cold forming blister laminate. One of laminate's main benefits is that it completely seals out both oxygen and water, extending the shelf life of the product due to the laminate's thicker foil. However, a significant issue for these producers is the slower manufacturing speed as compared to thermoforming, which impacts the supply and demand chain as a whole. One of the challenges experienced by producers is the lack of transparency of the package and the increasing size of the blister card. The cold form blister packaging has grown due to rising healthcare product demand and the viability of the pharmaceutical and medical industries. And it is expected that Over the forecast year, this tendency is anticipated to persist.

Pharmaceuticals and medical devices are both included in the healthcare sector's substantial use of cold form blister packaging. It is employed by the pharmaceutical sector to package a variety of goods, such as tablets, capsules, medications, vials, ampoules, syringes, and liquids. Cold form foils with features like push-through, peelable, peel-push, tear-open, and child resistance are produced depending on the needs of pharmaceutical clients across the world. These specific solutions are provided by international blister pack manufacturers for newly introduced therapeutic areas, novel procedures, and other specialist healthcare uses.

US Cold Blister Packaging Effective Choice Pharmaceutical Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cold Blister Packaging Effective Choice Pharmaceutical Market size was valued at USD 3.44 billion in 2021 and is poised to grow from USD 3.70 billion in 2022 to USD 6.60 by 2030, at a CAGR of 7.5% during the forecast period (2023-2030).

The cold blister packaging effective choice pharmaceutical market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Amcor plc', 'Bemis Company, Inc. (now part of Amcor)', 'WestRock Company', 'Constantia Flexibles Group GmbH', 'Uflex Ltd.', 'Bilcare Limited', 'Tekni-Plex, Inc.', 'Klöckner Pentaplast Group', 'Huhtamaki Group', 'Winpak Ltd.', 'Essentra plc', 'Wipak Group', 'Almac Group', 'DPH (Delhi Print House)', 'R-Pharm Germany GmbH', 'Auger Packaging', 'Keystone Folding Box Co.', 'MPI Label Systems', 'Multivac Group', 'Romaco Group'

The main factor driving market expansion is the rise in the use of blister packaging for tablets and capsules. blister packaging is extensively employed in tablets and capsules. Individual capsules are frequently kept in a bigger carton using blister packing, which shields the contents from contamination. The most common material structure utilized to produce blister packs all around the world is the OPA/Al/PVC multilayer structure. Additionally, blister packs can shield materials from environmental influences including contamination and humidity for prolonged periods. Thus due to its convenient usage it has driven the cold blister packaging effective choice pharmaceutical industry significantly.

The expansion of the generic market, escalation of financial investment in the pharmaceutical, marketing products through e-commerce, and fast rising drug delivery industry are further predicted to enhance the market growth. The market dynamics have been altered by oral ingestible containers, inhalers, nasal sprays, and other comparable items, which are expected to encourage the expansion of pharmaceutical packaging. The demand for packaging is rising as a result of rising customer demands for convenience and better sealing characteristics, increased demand for a variety of products, and enhanced environmental norms.

The Asia Pacific region dominated the cold blister packaging effective choice pharmaceutical industry in 2021. China had the highest revenue share—more than 30.0%. The country's access to raw materials like PVC and aluminium is assisting the market's expansion. According to a report from the Government of Canada, the China had  produced 36 million tonnes in 2019, followed by India, Russia, and Canada,   The value of the market is being driven by the presence of significant players in the area, including Shanghai Haishun New Pharmaceutical Packaging Ltd. and Ningbo Dragon Packaging Technology Co., Ltd. Market Dynamics. Further, the increasing prevalence of contract manufacturing across growing countries like China and India is contributing to the market growth in the country. India is anticipated to expand at the fastest rate IN the forecasting year. This is because of rising investments in the region's healthcare sector and government support for the growth and progress of the pharmaceutical industry in the country. Another important element promoting the development of the market in the nation is the rising prevalence of chronic disorders among the populace.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cold Blister Packaging Effective Choice Pharmaceutical Market

Report ID: SQMIG35I2252

$5,300
BUY NOW GET FREE SAMPLE